Neoadjuvant chemotherapy for breast cancer increases the rate of breast conservation: Results from the national cancer database

Journal of the American College of Surgeons

Volumn 220, Issue 6, 2015, Pages 1063-1069

  Killelea, Brigid K ^a   Yang, Vicky Q ^a   Mougalian, Sarah ^a   Horowitz, Nina R ^a   Pusztai, Lajos ^a   Chagpar, Anees B ^a   Lannin, Donald R ^a  

^a YALE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NON PROFIT ORGANIZATION; ORGAN PRESERVATION; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUMOR VOLUME; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; AGED; BREAST NEOPLASMS; EVALUATION STUDY; FACTUAL DATABASE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SEGMENTAL MASTECTOMY; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; UNITED STATES; UTILIZATION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DATABASES, FACTUAL; FEMALE; HUMANS; LOGISTIC MODELS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84929837082     PISSN: 10727515     EISSN: 18791190     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2015.02.011     Document Type: Article

References (12)

1. B. Fisher, A. Brown, and E. Mamounas Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18 J Clin Oncol 15 1997 2483 2493
2. P. Rastogi, S.J. Anderson, and H.D. Bear Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27 J Clin Oncol 26 2008 778 785
3. J.A. van der Hage, C.J. van de Velde, and J.P. Julien Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902 J Clin Oncol 19 2001 4224 4237
4. H.D. Bear, S. Anderson, and R.E. Smith Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27 J Clin Oncol 24 2006 2019 2027
5. K.D. Miller, W. McCaskill-Stenens, and J. Sisk Combination versus sequential doxorubicin and docetaxel as primary chemotherapy for breast cancer: A randomized pilot trial of the Hoosier Oncology Group J Clin Oncol 17 1999 3033 3037
6. S.D. Heys, A.W. Hutcheon, and T.K. Sarkar Neoadjuvant docetaxel in breast cancer: 3-year survival results from the Aberdeen trial Clin Breast Cancer 3 Suppl 2 2002 S69 74
7. T.J. Powles, T.F. Hickish, and A. Makris Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer J Clin Oncol 13 1995 547 552
8. C.J. Christy, D. Thorsteinsson, and B.J. Grube Preoperative chemotherapy decreases the need for re-excision of breast cancers between 2 and 4 cm diameter Ann Surg Oncol 16 2009 697 702
9. A.U. Buzdar, N.K. Ibrahim, and D. Francis Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer J Clin Oncol 23 2005 3676 3685
10. M. De Lena, R. Zucali, and G. Vignaotti Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer Cancer Chemother Pharmacol 1 1978 53 59
11. J.C. Boughey, F. Peintinger, and F. Meric-Bernstam Impact of preoperative versus postoperative chemotherapy on the extent and number of surgical procedures in patients treated in randomized clinical trials for breast cancer Ann Surg 244 2006 464 470
12. P. Cortazar, L. Zhang, and M. Untch Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis Lancet 384 2014 164 172